BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-21 05:00 |
BERGENBIO PRESENTING AT ARCTIC SECURITIES BIOTECH WEBINAR
|
English | 5.2 KB | ||
| 2021-04-19 05:00 |
BERGENBIO KUNNGJØR OPPDATERING FRA FASE-II UTPRØVINGSSTUDIER AV BEMCENTINIB I S…
|
Norwegian | 248.9 KB | ||
| 2021-04-19 05:00 |
BERGENBIO ANNOUNCES UPDATE FROM INVESTIGATIONAL PHASE II TRIALS ASSESSING BEMCE…
|
English | 227.2 KB | ||
| 2021-04-19 05:00 |
BERGENBIO KUNNGJØR OPPDATERING FRA FASE-II UTPRØVINGSSTUDIER AV BEMCENTINIB I S…
|
Norwegian | 10.3 KB | ||
| 2021-04-19 05:00 |
BERGENBIO ANNOUNCES UPDATE FROM INVESTIGATIONAL PHASE II TRIALS ASSESSING BEMCE…
|
English | 10.1 KB | ||
| 2021-03-31 06:33 |
Flagging
|
Swedish | 866 bytes | ||
| 2021-03-30 20:04 |
BERGENBIO ANNOUNCES STOPPED RECRUITMENT TO THE BEMCENTINIB ARM IN UK ACCORD COV…
|
English | 185.4 KB | ||
| 2021-03-30 20:04 |
BERGENBIO ANNOUNCES STOPPED RECRUITMENT TO THE BEMCENTINIB ARM IN UK ACCORD COV…
|
English | 7.0 KB | ||
| 2021-03-19 17:13 |
BERGENBIO ASA: MINUTES FROM THE ANNUAL GENERAL MEETING
|
Norwegian | 216.4 KB | ||
| 2021-03-19 17:13 |
BERGENBIO ASA: MINUTES FROM THE ANNUAL GENERAL MEETING
|
Norwegian | 1014.9 KB | ||
| 2021-03-19 17:13 |
BERGENBIO ASA: MINUTES FROM THE ANNUAL GENERAL MEETING
|
English | 1.6 KB | ||
| 2021-03-15 15:40 |
BERGENBIO ASA: DISCLOSURE OF LARGE SHAREHOLDINGS-PROXIES RECEIVED IN CONNECTION…
|
English | 138.8 KB | ||
| 2021-03-15 15:40 |
BERGENBIO ASA: DISCLOSURE OF LARGE SHAREHOLDINGS-PROXIES RECEIVED IN CONNECTION…
|
English | 2.4 KB | ||
| 2021-03-12 06:00 |
BERGENBIO COMPLETES ENROLMENT INTO LATEST COHORT OF PHASE II BEMCENTINIB COMBIN…
|
English | 181.9 KB | ||
| 2021-03-12 06:00 |
BERGENBIO COMPLETES ENROLMENT INTO LATEST COHORT OF PHASE II BEMCENTINIB COMBIN…
|
English | 6.7 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
